INIS
drugs
100%
cancer
75%
therapy
72%
nanoparticles
67%
applications
56%
reviews
52%
delivery
50%
in vitro
44%
drug delivery
44%
surfaces
42%
toxicity
40%
design
38%
evaluation
36%
in vivo
30%
stability
29%
proteins
29%
liposomes
29%
hplc
27%
ph value
24%
mice
24%
interactions
24%
biological availability
22%
solubility
22%
peptides
22%
optimization
22%
synthesis
21%
carriers
21%
breasts
20%
comparative evaluations
20%
nanostructures
20%
lipids
19%
theranostics
19%
skin
17%
solids
17%
management
16%
organometallic compounds
16%
size
16%
brain
15%
levels
15%
diseases
15%
polymers
14%
performance
14%
validation
14%
humans
14%
efficiency
14%
detection
14%
concentration
13%
rats
13%
administration
13%
stimuli
13%
tumors
12%
assessments
12%
gels
12%
receptors
11%
values
11%
nanomaterials
11%
testes
11%
gold
10%
molecules
10%
nanotechnology
10%
oxidation
10%
investigations
10%
lactoferrin
10%
antibiotics
10%
dispersions
10%
nose
9%
antioxidants
9%
manufacturing
9%
uptake
9%
buffers
9%
retention
9%
dissolution
9%
genes
9%
graphene
9%
screws
9%
oocytes
9%
doses
9%
hyaluronic acid
8%
uracils
8%
patients
8%
glioblastomas
8%
water
8%
range
8%
high-performance liquid chromatography
8%
phosphates
8%
pharmaceuticals
8%
barium
7%
ferrites
7%
iron
7%
spermatozoa
7%
extrusion
7%
dendrimers
7%
carbon
7%
data
7%
molecular dynamics method
7%
tissues
7%
chemotherapy
7%
inflammation
7%
solutions
7%
particles
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
33%
Malignant Neoplasm
31%
Bioavailability
22%
Reverse Phase High Performance Liquid Chromatography
21%
Liposome
20%
High Performance Liquid Chromatography
20%
Nanocarrier
16%
Drug Delivery System
15%
Breast Cancer
14%
Drug Release
14%
Nanomaterial
14%
Small Interfering RNA
11%
Lactoferrin
10%
Asenapine
10%
Pharmacokinetics
10%
Metal Organic Framework
10%
Receptor
10%
Fluorouracil
9%
Peptides and Proteins
9%
Neoplasm
9%
Dosage Forms
9%
Hyaluronic Acid
8%
Antioxidant
8%
Chitosan
8%
Targeted Drug Delivery
8%
Swiss Webster Mouse
7%
Zeta Potential
7%
Chemotherapy
6%
SARS Coronavirus
6%
Amorphous Solid Dispersion
6%
Letrozole
6%
Glioblastoma
6%
Helicobacter Pylori
6%
Neuroblastoma
6%
Biocompatibility
6%
Buffer
6%
Differential Scanning Calorimetry
5%
Controlled Release
5%
Doxorubicin
5%
Skin Cancer
5%
Clinical Trial
5%
Biodistribution
5%
Disease
5%
Transferrin
5%
Drug Carrier
5%
Tablet
5%
Surfactant
5%
Blood-Brain Barrier
5%
Anticarcinogen
5%
Antiinfective Agent
5%
Dendrimer
5%
Biological Product
5%
Glibenclamide
5%